Recently, Dr. Robert Kalb, Director of the Les Turner ALS Center at Northwestern Medicine, sat down with the podcast “Breakthroughs” to discuss how the Les Turner ALS Center at Northwestern Medicine is at the forefront of discovering the cause and potential …
Phase 3 Clinical Drug Trial at Les Turner ALS Center at Northwestern Medicine
Our Les Turner ALS Center at Northwestern Medicine effectively connects the worlds of research and patient support to ensure the best care is provided and the brightest minds are working to find a cure. Unlike other organizations, our Center brings …
Introducing Fundraise Your Way
FUNDRAISE YOUR WAY A NEW FUNDRAISING PROGRAM MADE JUST FOR YOU You asked for it and today we’re so excited to introduce our brand new community based fundraising program built just for you! Fundraise Your Way (FYW) gives you the …
Meet Our 2018 ALS Walk for Life Team Chair
Join The Rhode to a Cure at the 2018 ALS Walk for Life.
Kiskinis lab work published in journal Stem Cell Reports
We are thrilled to share that Dr. Evangelos Kiskinis, one of the lead researchers at the Les Turner ALS Center at Northwestern Medicine, has been published in the journal Stem Cell Reports. From Dr. Kiskinis: “In our most recent manuscript, which …
One-Year Anniversary of FDA-approved ALS Treatment Radicava
This May marks the one-year anniversary of the FDA-approval of Radicava, the only FDA-approved ALS treatment option in the last 20 years. Radicava’s developer, Mitsubishi Tanabe Pharma Corporation (MTPC) began researching ALS in 2001 through an interactive clinical platform that …
Kiskinis lab work published in journal Cell Stem Cell
We are excited to share a newly published finding from Dr. Evangelos Kiskinis, one of the lead researchers at the Les Turner ALS Center at Northwestern Medicine. A few words from Dr. Kiskinis: “In our latest manuscript, which was published …
Machine learning: Calculating disease
“Machine learning might identify patients earlier, predict their outcomes better, and assign them more efficiently to appropriate clinical trials.” Read the full article highlighting machine learning in relation to ALS, on the Nature International Journal of Science, here. Explore More …
Communicate the “Who, What, and Why,” at All Stages of Your Journey: 5 Tips With Harvey Gaffen
“Open, honest communication has helped us find and secure resources, publicize the compelling stories of the people we serve, showcase our accomplishments, and attract new donors.” “I had the pleasure of interviewing Harvey Gaffen, president emeritus of the Les Turner ALS …
Column: Amid the ugliness of ALS lies the beauty of love
December 29, 2017 – Everything is an opportunity for something. That’s what Holly Kahan told a group of women at a recent networking meeting I attended. That seemed like a pretty reasonable statement, which can be applicable to many difficult …
